Global Azelastine Industry Growth and Trends Forecast to 2031

Summary

Azelastine is an antihistamine. It works by preventing the effects of a substance called histamine, which produced by the body. Histamine can cause itching, sneezing, runny nose, and watery eyes.

Azelastine is a medication primarily used as a nasal spray to treat hay fever and allergy symptoms including runny nose, sneezing, and itchy nose and as eye drops for allergic conjunctivitis. Other uses may include asthma and skin rashes for which is taken by mouth

According to APO Research, The global Azelastine market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Azelastine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Azelastine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Azelastine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Azelastine include Viatris, Apotex, Yunfeng Pharma, Sun Pharma, Amneal Pharmaceuticals, Zhongsheng Pharma, Hikma Pharmaceuticals, Perrigo and Alkem Labs, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Azelastine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Azelastine.

The Azelastine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Azelastine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Azelastine Segment by Company

Viatris
Apotex
Yunfeng Pharma
Sun Pharma
Amneal Pharmaceuticals
Zhongsheng Pharma
Hikma Pharmaceuticals
Perrigo
Alkem Labs
Jiangxi Zhenshiming Pharmaceutical

Azelastine Segment by Type

Nasal Spray
Eye Drops
Others

Azelastine Segment by Distribution Channel
Hospital
Retail Pharmacy
Others

Azelastine Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azelastine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Azelastine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azelastine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Azelastine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Azelastine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview

1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Azelastine Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Azelastine Sales Estimates and Forecasts (2020-2031)
1.3 Azelastine Market by Type
1.3.1 Nasal Spray
1.3.2 Eye Drops
1.3.3 Others
1.4 Global Azelastine Market Size by Type
1.4.1 Global Azelastine Market Size Overview by Type (2020-2031)
1.4.2 Global Azelastine Historic Market Size Review by Type (2020-2025)
1.4.3 Global Azelastine Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Azelastine Sales Breakdown by Type (2020-2025)
1.5.2 Europe Azelastine Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Azelastine Sales Breakdown by Type (2020-2025)
1.5.4 South America Azelastine Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Azelastine Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics

2.1 Azelastine Industry Trends
2.2 Azelastine Industry Drivers
2.3 Azelastine Industry Opportunities and Challenges
2.4 Azelastine Industry Restraints
3 Market Competitive Landscape by Company

3.1 Global Top Players by Azelastine Revenue (2020-2025)
3.2 Global Top Players by Azelastine Sales (2020-2025)
3.3 Global Top Players by Azelastine Price (2020-2025)
3.4 Global Azelastine Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Azelastine Major Company Production Sites & Headquarters
3.6 Global Azelastine Company, Product Type & Application
3.7 Global Azelastine Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Azelastine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Azelastine Players Market Share by Revenue in 2024
3.8.3 2023 Azelastine Tier 1, Tier 2, and Tier 3
4 Azelastine Regional Status and Outlook

4.1 Global Azelastine Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Azelastine Historic Market Size by Region
4.2.1 Global Azelastine Sales in Volume by Region (2020-2025)
4.2.2 Global Azelastine Sales in Value by Region (2020-2025)
4.2.3 Global Azelastine Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Azelastine Forecasted Market Size by Region
4.3.1 Global Azelastine Sales in Volume by Region (2026-2031)
4.3.2 Global Azelastine Sales in Value by Region (2026-2031)
4.3.3 Global Azelastine Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Azelastine by Application

5.1 Azelastine Market by Distribution Channel
5.1.1 Hospital
5.1.2 Retail Pharmacy
5.1.3 Others
5.2 Global Azelastine Market Size by Distribution Channel
5.2.1 Global Azelastine Market Size Overview by Application (2020-2031)
5.2.2 Global Azelastine Historic Market Size Review by Application (2020-2025)
5.2.3 Global Azelastine Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Distribution Channel
5.3.1 North America Azelastine Sales Breakdown by Distribution Channel (2020-2025)
5.3.2 Europe Azelastine Sales Breakdown by Distribution Channel (2020-2025)
5.3.3 Asia-Pacific Azelastine Sales Breakdown by Distribution Channel (2020-2025)
5.3.4 South America Azelastine Sales Breakdown by Distribution Channel (2020-2025)
5.3.5 Middle East and Africa Azelastine Sales Breakdown by Distribution Channel (2020-2025)
6 Company Profiles

6.1 Viatris
6.1.1 Viatris Comapny Information
6.1.2 Viatris Business Overview
6.1.3 Viatris Azelastine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Viatris Azelastine Product Portfolio
6.1.5 Viatris Recent Developments
6.2 Apotex
6.2.1 Apotex Comapny Information
6.2.2 Apotex Business Overview
6.2.3 Apotex Azelastine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Apotex Azelastine Product Portfolio
6.2.5 Apotex Recent Developments
6.3 Yunfeng Pharma
6.3.1 Yunfeng Pharma Comapny Information
6.3.2 Yunfeng Pharma Business Overview
6.3.3 Yunfeng Pharma Azelastine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Yunfeng Pharma Azelastine Product Portfolio
6.3.5 Yunfeng Pharma Recent Developments
6.4 Sun Pharma
6.4.1 Sun Pharma Comapny Information
6.4.2 Sun Pharma Business Overview
6.4.3 Sun Pharma Azelastine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sun Pharma Azelastine Product Portfolio
6.4.5 Sun Pharma Recent Developments
6.5 Amneal Pharmaceuticals
6.5.1 Amneal Pharmaceuticals Comapny Information
6.5.2 Amneal Pharmaceuticals Business Overview
6.5.3 Amneal Pharmaceuticals Azelastine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Amneal Pharmaceuticals Azelastine Product Portfolio
6.5.5 Amneal Pharmaceuticals Recent Developments
6.6 Zhongsheng Pharma
6.6.1 Zhongsheng Pharma Comapny Information
6.6.2 Zhongsheng Pharma Business Overview
6.6.3 Zhongsheng Pharma Azelastine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zhongsheng Pharma Azelastine Product Portfolio
6.6.5 Zhongsheng Pharma Recent Developments
6.7 Hikma Pharmaceuticals
6.7.1 Hikma Pharmaceuticals Comapny Information
6.7.2 Hikma Pharmaceuticals Business Overview
6.7.3 Hikma Pharmaceuticals Azelastine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hikma Pharmaceuticals Azelastine Product Portfolio
6.7.5 Hikma Pharmaceuticals Recent Developments
6.8 Perrigo
6.8.1 Perrigo Comapny Information
6.8.2 Perrigo Business Overview
6.8.3 Perrigo Azelastine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Perrigo Azelastine Product Portfolio
6.8.5 Perrigo Recent Developments
6.9 Alkem Labs
6.9.1 Alkem Labs Comapny Information
6.9.2 Alkem Labs Business Overview
6.9.3 Alkem Labs Azelastine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Alkem Labs Azelastine Product Portfolio
6.9.5 Alkem Labs Recent Developments
6.10 Jiangxi Zhenshiming Pharmaceutical
6.10.1 Jiangxi Zhenshiming Pharmaceutical Comapny Information
6.10.2 Jiangxi Zhenshiming Pharmaceutical Business Overview
6.10.3 Jiangxi Zhenshiming Pharmaceutical Azelastine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jiangxi Zhenshiming Pharmaceutical Azelastine Product Portfolio
6.10.5 Jiangxi Zhenshiming Pharmaceutical Recent Developments
7 North America by Country

7.1 North America Azelastine Sales by Country
7.1.1 North America Azelastine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Azelastine Sales by Country (2020-2025)
7.1.3 North America Azelastine Sales Forecast by Country (2026-2031)
7.2 North America Azelastine Market Size by Country
7.2.1 North America Azelastine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Azelastine Market Size by Country (2020-2025)
7.2.3 North America Azelastine Market Size Forecast by Country (2026-2031)
8 Europe by Country

8.1 Europe Azelastine Sales by Country
8.1.1 Europe Azelastine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Azelastine Sales by Country (2020-2025)
8.1.3 Europe Azelastine Sales Forecast by Country (2026-2031)
8.2 Europe Azelastine Market Size by Country
8.2.1 Europe Azelastine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Azelastine Market Size by Country (2020-2025)
8.2.3 Europe Azelastine Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country

9.1 Asia-Pacific Azelastine Sales by Country
9.1.1 Asia-Pacific Azelastine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Azelastine Sales by Country (2020-2025)
9.1.3 Asia-Pacific Azelastine Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Azelastine Market Size by Country
9.2.1 Asia-Pacific Azelastine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Azelastine Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Azelastine Market Size Forecast by Country (2026-2031)
10 South America by Country

10.1 South America Azelastine Sales by Country
10.1.1 South America Azelastine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Azelastine Sales by Country (2020-2025)
10.1.3 South America Azelastine Sales Forecast by Country (2026-2031)
10.2 South America Azelastine Market Size by Country
10.2.1 South America Azelastine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Azelastine Market Size by Country (2020-2025)
10.2.3 South America Azelastine Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country

11.1 Middle East and Africa Azelastine Sales by Country
11.1.1 Middle East and Africa Azelastine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Azelastine Sales by Country (2020-2025)
11.1.3 Middle East and Africa Azelastine Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Azelastine Market Size by Country
11.2.1 Middle East and Africa Azelastine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Azelastine Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Azelastine Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis

12.1 Azelastine Value Chain Analysis
12.1.1 Azelastine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Azelastine Production Mode & Process
12.2 Azelastine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Azelastine Distributors
12.2.3 Azelastine Customers
13 Concluding Insights
14 Appendix

14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings